Albert L Reese Jr is Director of Lexaria Bioscience Corp.. Currently has a direct ownership of 10,917 shares of LEXX, which is worth approximately $23,908. The most recent transaction as insider was on May 24, 2022, when has been sold 5,000 shares (Common Shares) at a price of $1.96 per share, resulting in proceeds of $9,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.9K
0% 3M change
0% 12M change
Total Value Held $23,908

ALBERT L REESE Jr Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 24 2022
BUY
Grant, award, or other acquisition
$9,800 $1.96 p/Share
5,000 Added 31.41%
10,917 Common Shares
May 20 2022
BUY
Grant, award, or other acquisition
$3,616 $2.01 p/Share
1,799 Added 23.32%
5,917 Common Shares
May 19 2022
BUY
Grant, award, or other acquisition
$3,017 $2.01 p/Share
1,501 Added 26.71%
4,118 Common Shares
May 18 2022
BUY
Grant, award, or other acquisition
$3,417 $2.01 p/Share
1,700 Added 39.38%
2,617 Common Shares
ALR

Albert L Reese Jr

Director

Track Institutional and Insider Activities on LEXX

Follow Lexaria Bioscience Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LEXX shares.

Notify only if

Insider Trading

Get notified when an Lexaria Bioscience Corp. insider buys or sells LEXX shares.

Notify only if

News

Receive news related to Lexaria Bioscience Corp.

Track Activities on LEXX